Evidence map›Paper›PMID 28878038›Full record

ArticleOpen biology2017

The requirement of Mettl3-promoted

Kensuke Kudou, Tetsuro Komatsu, Jumpei Nogami, Kazumitsu Maehara, Akihito Harada, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara, Yasuyuki Ohkawa

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 100 citations in OpenAlex.

  1. The role of mNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Epigenetic control of skeletal muscle atrophy.Cellular & molecular biology letters · 2024
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Cloning of the RNA mVeterinary sciences · 2023
    Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kensuke KudouDivision of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, JST-CREST, Fukuoka 812-8582, Japan.
Tetsuro KomatsuDivision of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, JST-CREST, Fukuoka 812-8582, Japan.
Jumpei NogamiDivision of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, JST-CREST, Fukuoka 812-8582, Japan.
Kazumitsu MaeharaDivision of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, JST-CREST, Fukuoka 812-8582, Japan.
Akihito HaradaDivision of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, JST-CREST, Fukuoka 812-8582, Japan.
Hiroshi SaekiDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Eiji OkiDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Yoshihiko MaeharaDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Yasuyuki OhkawaDivision of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, JST-CREST, Fukuoka 812-8582, Japan yohkawa@bioreg.kyushu-u.ac.jp.ORCID 0000-0001-6440-9954
Kyushu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myogenic progenitor/stem cells retain their skeletal muscle differentiation potential by maintaining myogenic transcription factors such as MyoD. However, the mechanism of how MyoD expression is maintained in proliferative progenitor cells has not been elucidated. Here, we found that

Indexed as

5' Untranslated RegionsAdenosineAnimalsCell DifferentiationCell LineCell ProliferationELAV-Like Protein 1G2 PhaseGene Expression RegulationMethylationMethyltransferasesMiceMuscle DevelopmentMuscle, SkeletalMyoblastsMyoD Protein5' Untranslated RegionsAdenosineElavl1 protein, mouseELAV-Like Protein 1MethyltransferasesMettl3 protein, mouseMyoD1 myogenic differentiation proteinMyoD ProteinN-methyladenosineQuinolinesRNA, Small InterferingRO 3306ThiazolesThymidineHuRm6A-sequencingMettl3MyoDRNA processingsplicing

Identifiers

PMID28878038
PMCPMC5627051
OpenAlexW2753095878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.